rivastigmine tartrate capsule

INDICATIONS AND USAGE Rivastigmine Tartrate Capsule is indicated for the treatment of mild to moderate dementia of the Alzheimer’s type. Rivastigmine Tartrate Capsule is indicated for the treatment of mild to moderate dementia associated with Parkinson’s disease. The dementia of Parkinson’s disease is purportedly characterized by impairments in executive function, memory retrieval, and attention, in patients with an established diagnosis of Parkinson’s disease. The diagnosis of the dementia of Parkinson’s disease, however, can reliably be made in patients in whom a progressive dementia syndrome occurs (without the necessity to document the specific deficits described above) at least 2 years after a diagnosis of Parkinson’s disease has been made, and in whom other causes of dementia have been ruled out (see CLINICAL PHARMACOLOGY, Clinical Trial Data ).

physicians total care, inc.

FDA Reported Adverse Reactions
`[1] constipation` `[2] drug ineffective` `[3] fall` `[4] treatment failure` `[5] pain` `[6] chronic kidney disease` `[7] nausea` `[8] hypotension` `[9] fatigue` `[10] off label use`

6 years ago

CAPSULE ORANGE 148 148

HOW SUPPLIED Rivastigmine Tartrate capsules equivalent to 6 mg of rivastigmine base are available as follows: 6 mg capsule – orange, “148” is printed in black on the body and cap of the capsule. Bottles of 60's with Child Resistant Cap NDC 54868-6145-0 Storage: Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [see USP Controlled Room Temperature]. Dispense in a tight container.

More pills like CAPSULE 148 148

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

rivastigmine tartrate capsule

FDA Reported Adverse Reactions [1] constipation [2] drug ineffective [3] fall [4] treatment failure [5] pain [6] chronic kidney disease [7] nausea [8] hypotension [9] fatigue [10] off label use

CAPSULE ORANGE 148 148

More pills like CAPSULE 148 148

FDA Reported Adverse Reactions
`[1] constipation` `[2] drug ineffective` `[3] fall` `[4] treatment failure` `[5] pain` `[6] chronic kidney disease` `[7] nausea` `[8] hypotension` `[9] fatigue` `[10] off label use`